DK534188D0 - Hidtil ukendt vaccine - Google Patents

Hidtil ukendt vaccine

Info

Publication number: DK534188D0
Authority: DK; Denmark
Prior art keywords: compositions; vaccine; unknown; inactivating; prophylaxis
Prior art date: 1987-09-28

Application number

DK534188A

Other languages

English (en)

Other versions

DK534188A (da

DK175379B1 (da

Inventor

Dale Bordt

Hans Draayer

Original Assignee

Beecham Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-09-28

Filing date

1988-09-26

Publication date

1988-09-26

1988-09-26 Application filed by Beecham Inc filed Critical Beecham Inc

1988-09-26 Publication of DK534188D0 publication Critical patent/DK534188D0/da

1989-03-29 Publication of DK534188A publication Critical patent/DK534188A/da

2004-09-20 Application granted granted Critical

2004-09-20 Publication of DK175379B1 publication Critical patent/DK175379B1/da

Links

229960005486 vaccine Drugs 0.000 title 1
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
241000894006 Bacteria Species 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
241000700605 Viruses Species 0.000 abstract 1
229960005070 ascorbic acid Drugs 0.000 abstract 1
235000010323 ascorbic acid Nutrition 0.000 abstract 1
239000011668 ascorbic acid Substances 0.000 abstract 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
229910001385 heavy metal Inorganic materials 0.000 abstract 1
229940031551 inactivated vaccine Drugs 0.000 abstract 1
230000000415 inactivating effect Effects 0.000 abstract 1
150000002500 ions Chemical class 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
239000001301 oxygen Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
- A61K39/225—Porcine transmissible gastroenteritis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/265—Infectious rhinotracheitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20061—Methods of inactivation or attenuation
- C12N2770/20063—Methods of inactivation or attenuation by chemical treatment

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Mycology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Pulmonology (AREA)
Biotechnology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Steroid Compounds (AREA)
Catalysts (AREA)
Saccharide Compounds (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

DK198805341A 1987-09-28 1988-09-26 Anvendelse af transmitterbart svine-gastro-enteritisvirus samt fremgangsmåde til fremstilling af en vaccine DK175379B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10182287A	1987-09-28	1987-09-28
US10182287		1987-09-28

Publications (3)

Publication Number	Publication Date
DK534188D0 true DK534188D0 (da)	1988-09-26
DK534188A DK534188A (da)	1989-03-29
DK175379B1 DK175379B1 (da)	2004-09-20

Family

ID=22286587

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK198805342A DK175308B1 (da)	1987-09-28	1988-09-26	En vaccinekomposition omfattende et inaktiveret virus eller bakterium, fremgangsmåde til fremstilling deraf samt anvendelsen af en substans eller en komposition i fremstillingen deraf
DK198805341A DK175379B1 (da)	1987-09-28	1988-09-26	Anvendelse af transmitterbart svine-gastro-enteritisvirus samt fremgangsmåde til fremstilling af en vaccine

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK198805342A DK175308B1 (da)	1987-09-28	1988-09-26	En vaccinekomposition omfattende et inaktiveret virus eller bakterium, fremgangsmåde til fremstilling deraf samt anvendelsen af en substans eller en komposition i fremstillingen deraf

Country Status (14)

Country	Link
EP (2)	EP0310317B1 (da)
JP (2)	JP2733844B2 (da)
KR (2)	KR890004725A (da)
AT (2)	ATE117899T1 (da)
AU (2)	AU624339B2 (da)
CA (2)	CA1332919C (da)
DE (2)	DE3886332T2 (da)
DK (2)	DK175308B1 (da)
ES (2)	ES2067474T3 (da)
GR (1)	GR3015608T3 (da)
IE (2)	IE60950B1 (da)
NZ (2)	NZ226332A (da)
PT (2)	PT88590B (da)
ZA (2)	ZA887196B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE117899T1 (de) *	1987-09-28	1995-02-15	Beecham Inc	Tgev-virus vom schwein als impfstoff für hunde.
CA2064558C (en) *	1989-09-25	2001-01-30	Ian B. Pragnell	Method for inhibiting growth of stem cells
US5276142A (en) *	1989-12-11	1994-01-04	American Cyanamid Company	Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis
EP0460480B1 (en) *	1990-06-07	1996-01-24	Bayer Corporation	Bacterin for the treatment of necrophorum diseases and a method for the production thereof
US6057436A (en) *	1990-11-14	2000-05-02	Pfizer Inc.	Canine coronavirus S gene and uses therefor
US6372224B1 (en)	1990-11-14	2002-04-16	Pfizer Inc.	Canine coronavirus S gene and uses therefor
JPH0813753B2 (ja) *	1992-05-22	1996-02-14	株式会社微生物化学研究所	牛伝染性鼻気管炎ウイルス感染症、牛ウイルス性下痢−粘膜病ウイルス感染症、パラインフルエンザ３型ウイルス感染症、牛ｒｓウイルス感染症および牛アデノ７型ウイルス感染症５種混合生ワクチン
BR9307190A (pt) *	1992-10-05	1999-03-30	Sanofi Animal Health Inc	Processo de vacinação de um animal contra um agente infeccioso vacina e kit de vacina
JP2521226B2 (ja) *	1993-01-28	1996-08-07	株式会社微生物化学研究所	犬用多種混合ワクチン
EP0612532A3 (en) *	1993-02-26	1998-02-04	Solvay Animal Health, Inc.	Canine coronavirus vaccine from feline enteric coronavirus
US5750112A (en) *	1993-02-26	1998-05-12	Solvay Animal Health, Inc.	Canine coronavirus vaccine from feline enteric coronavirus
US5362442A (en)	1993-07-22	1994-11-08	2920913 Canada Inc.	Method for sterilizing products with gamma radiation
RU2142817C1 (ru) *	1993-08-06	1999-12-20	Коннот Лабораториз Лимитед	Инактивированные вакцины респираторно-синцитиального вируса
CA2184132C (en) *	1995-09-21	2011-03-15	Kristina J. Hennessy	An adjuvanted vaccine which is substantially free of non-host albumin
US6682746B2 (en)	1995-09-21	2004-01-27	Kristina J. Hennessy	Adjuvanted vaccine which is substantially free of non-host albumin
US5853715A (en) *	1996-08-16	1998-12-29	Bayer Corporation	Cross-protective equine herpesvirus preparations and method of making and using the same
UA78180C2 (uk) *	1997-10-03	2007-03-15	Меріаль	Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
EP0978286A1 (en) *	1998-08-07	2000-02-09	Bayer Corporation	Cross-protective equine herpesvirus preparations and method of making and using the same
US6682695B2 (en)	2001-03-23	2004-01-27	Clearant, Inc.	Methods for sterilizing biological materials by multiple rates
US6696060B2 (en)	2001-06-14	2004-02-24	Clearant, Inc.	Methods for sterilizing preparations of monoclonal immunoglobulins
US6946098B2 (en)	2001-08-10	2005-09-20	Clearant, Inc.	Methods for sterilizing biological materials
US6749851B2 (en)	2001-08-31	2004-06-15	Clearant, Inc.	Methods for sterilizing preparations of digestive enzymes
US7252799B2 (en)	2001-08-31	2007-08-07	Clearant, Inc.	Methods for sterilizing preparations containing albumin
US20030095890A1 (en)	2001-09-24	2003-05-22	Shirley Miekka	Methods for sterilizing biological materials containing non-aqueous solvents
US6783968B2 (en)	2001-09-24	2004-08-31	Clearant, Inc.	Methods for sterilizing preparations of glycosidases
US6908591B2 (en)	2002-07-18	2005-06-21	Clearant, Inc.	Methods for sterilizing biological materials by irradiation over a temperature gradient
US7682619B2 (en)	2006-04-06	2010-03-23	Cornell Research Foundation, Inc.	Canine influenza virus
CN103709248B (zh) *	2013-12-24	2019-07-16	北京大北农科技集团股份有限公司动物医学研究中心	一种抗猪传染性胃肠炎病毒高免血清及其制备方法
DE202020001666U1 (de)	2020-04-21	2020-06-08	Walther Enßlin	Imprägnierung der Oberfläche von Kleidung, Schutzkleidung, Gewebehandschuhen gegen Viren aus den Tröpfchen der Atemluft
DE202020003865U1 (de)	2020-09-11	2021-09-22	Karin Emde	Einfangen und Vernichten von Viren und andere Mikroorganismen in Raumluft und Raumluftfiltern
DE102021001635A1 (de)	2021-03-27	2022-09-29	Karin Emde	Abfangen und Vernichten von Viren und andere Mikroorganismen auf Oberflächen, in Raumluft, in der Abluft von Staubsaugern und in Raumluftfiltern.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3145144A (en) *	1951-08-09	1964-08-18	Takeda Pharmacentical Ind Ltd	Process for manufacturing chromium treated vaccines
FR1488212A (fr) *	1964-06-22	1967-07-13	Behringwerke Ag	Procédé permettant d'atténuer le virus de la fièvre aphteuse
CH466894A (de) *	1964-09-22	1968-12-31	Diamond Lab Inc	Verfahren zur Herstellung eines Vakzins gegen infektiöse Gastroenteritis
US3925544A (en) *	1971-07-12	1975-12-09	Univ Southern Illinois	Bovine vaccines and methods of making and using same
US3907986A (en) *	1972-12-18	1975-09-23	Rit Rech Ind Therapeut	Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof
JPS5531762B2 (da) *	1973-03-28	1980-08-20
DE2860895D1 (en) *	1977-07-22	1981-11-05	Merck & Co Inc	Parainfluenza virus vaccine and its preparation
JPS55104215A (en) *	1979-02-06	1980-08-09	Merck & Co Inc	Parainfluenza virus vaccine and its manufacture
GB8502399D0 (en) *	1985-01-31	1985-03-06	Akzo Nv	Canine parvovirus vaccines
ATE117899T1 (de) *	1987-09-28	1995-02-15	Beecham Inc	Tgev-virus vom schwein als impfstoff für hunde.

1988
- 1988-09-26 AT AT88308907T patent/ATE117899T1/de not_active IP Right Cessation
- 1988-09-26 ES ES88308907T patent/ES2067474T3/es not_active Expired - Lifetime
- 1988-09-26 AU AU22814/88A patent/AU624339B2/en not_active Ceased
- 1988-09-26 NZ NZ226332A patent/NZ226332A/xx unknown
- 1988-09-26 EP EP88308908A patent/EP0310317B1/en not_active Expired - Lifetime
- 1988-09-26 DK DK198805342A patent/DK175308B1/da not_active IP Right Cessation
- 1988-09-26 PT PT88590A patent/PT88590B/pt active IP Right Grant
- 1988-09-26 CA CA000578383A patent/CA1332919C/en not_active Expired - Fee Related
- 1988-09-26 IE IE290988A patent/IE60950B1/en not_active IP Right Cessation
- 1988-09-26 EP EP88308907A patent/EP0310316B1/en not_active Expired - Lifetime
- 1988-09-26 DK DK198805341A patent/DK175379B1/da not_active IP Right Cessation
- 1988-09-26 PT PT88591A patent/PT88591B/pt not_active IP Right Cessation
- 1988-09-26 AU AU22843/88A patent/AU624081B2/en not_active Ceased
- 1988-09-26 ES ES88308908T patent/ES2061673T3/es not_active Expired - Lifetime
- 1988-09-26 IE IE290888A patent/IE66015B1/en not_active IP Right Cessation
- 1988-09-26 AT AT88308908T patent/ATE98680T1/de not_active IP Right Cessation
- 1988-09-26 DE DE88308908T patent/DE3886332T2/de not_active Expired - Fee Related
- 1988-09-26 DE DE3852918T patent/DE3852918T2/de not_active Expired - Fee Related
- 1988-09-26 ZA ZA887196A patent/ZA887196B/xx unknown
- 1988-09-26 ZA ZA887195A patent/ZA887195B/xx unknown
- 1988-09-26 CA CA000578384A patent/CA1331562C/en not_active Expired - Fee Related
- 1988-09-26 NZ NZ226333A patent/NZ226333A/xx unknown
- 1988-09-28 JP JP63243735A patent/JP2733844B2/ja not_active Expired - Fee Related
- 1988-09-28 KR KR1019880012563A patent/KR890004725A/ko not_active Ceased
- 1988-09-28 KR KR1019880012562A patent/KR0135426B1/ko not_active Expired - Fee Related
- 1988-09-28 JP JP63243734A patent/JP2715114B2/ja not_active Expired - Lifetime
1995
- 1995-03-23 GR GR950400684T patent/GR3015608T3/el unknown

Also Published As

Publication number	Publication date
ZA887196B (en)	1989-07-26
PT88591A (pt)	1988-10-01
AU2284388A (en)	1989-04-06
IE882909L (en)	1989-03-28
JPH01230532A (ja)	1989-09-14
NZ226333A (en)	1991-09-25
ES2061673T3 (es)	1994-12-16
KR0135426B1 (ko)	1998-04-23
DK534288A (da)	1989-03-29
CA1331562C (en)	1994-08-23
EP0310316A2 (en)	1989-04-05
DK534188A (da)	1989-03-29
DK175379B1 (da)	2004-09-20
KR890004728A (ko)	1989-05-09
GR3015608T3 (en)	1995-06-30
PT88590A (pt)	1988-10-01
IE60950B1 (en)	1994-09-07
DE3886332D1 (de)	1994-01-27
EP0310317B1 (en)	1993-12-15
CA1332919C (en)	1994-11-08
DE3852918D1 (de)	1995-03-16
AU624339B2 (en)	1992-06-11
EP0310317A2 (en)	1989-04-05
EP0310316B1 (en)	1995-02-01
IE66015B1 (en)	1995-11-29
IE882908L (en)	1989-03-28
NZ226332A (en)	1991-10-25
DE3886332T2 (de)	1994-03-31
AU624081B2 (en)	1992-06-04
ZA887195B (en)	1989-07-26
AU2281488A (en)	1989-04-06
EP0310317A3 (en)	1990-02-14
PT88590B (pt)	1993-04-30
EP0310316A3 (en)	1990-02-14
PT88591B (pt)	1992-11-30
DK534288D0 (da)	1988-09-26
JPH01230523A (ja)	1989-09-14
KR890004725A (ko)	1989-05-09
JP2733844B2 (ja)	1998-03-30
DE3852918T2 (de)	1995-07-13
ATE117899T1 (de)	1995-02-15
JP2715114B2 (ja)	1998-02-18
ES2067474T3 (es)	1995-04-01
ATE98680T1 (de)	1994-01-15
DK175308B1 (da)	2004-08-16

Legal Events

Date	Code	Title	Description
2007-04-30	PBP	Patent lapsed	Country of ref document: DK

Publication	Publication Date	Title
DK534188A (da)	1989-03-29	Hidtil ukendt vaccine
ATE366312T1 (de)	2007-07-15	Impfstoff und antitoxine zur behandlung und vorbeugung von c. difficile krankheiten
DE69433901D1 (de)	2004-08-19	Verbindungen und pharmazeutische zusammensetzungen zur behandlung und prophylaxe bakterieller infektionen
DE3684305D1 (de)	1992-04-16	Antivirales immunotherapeutisches mittel und dessen herstellung.
DK0400958T3 (da)	1996-01-15	Levende vacciner
DK561089D0 (da)	1989-11-09	Anvendelse af lactamimider til fremstilling af laegemidler
NO20013167L (no)	2001-06-22	Anvendelse av bisfosfonater for forebygging og behandling av infeksjonsprosesser
DK0406745T3 (da)	1995-02-27	Antibiotiske GE 2270 faktorer A1, A2, A3 og H
ATE220557T1 (de)	2002-08-15	Darmprotozoen-impfstoffe
DK605589D0 (da)	1989-11-30	Anvendelse af aminobenzocycloalkaner eller syreadditionssalte deraf til fremstilling af et farmaceutikum, saaledes fremstillet praeparat og dettes anvendelse
DE3750886D1 (de)	1995-02-02	Verwendung eines immunglobulinhaltigen Präparates zur Prophylaxe und Therapie von AIDS beim Menschen.
ITMI913493A1 (it)	1993-06-27	Dispositivo per la disinfezione o la immunizzazione di zone del corpo umano esposte al contagio, da germi, batteri e virus
DE69010523D1 (de)	1994-08-18	Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
HUP9700975A2 (hu)	1998-05-28	Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
DK0659341T3 (da)	2000-01-03	Fast insecticidt præparat
HUT71422A (en)	1995-11-28	Use of bradykinin-antagonists for producing pharmaceutical compositions for treating virus diseases
DK15088D0 (da)	1988-01-13	Antibakterielt lyofiliseret praeparat
MX9400210A (es)	1994-07-29	Tratamiento de infecciones virales.